Inefficiencies in Technology Transfer: Theory and Empirics

Markets for technology can promote innovation by allowing for division of labor in research and development. Some firms may specialize in the discovery of ideas, while others have a comparative advantage in later stages of development and marketing. However, these gains depend on the timing of technology transfer: the buyer of an idea should take over development at the stage at which he has an efficiency advantage. We show that in an environment with asymmetric information about the value of the idea and where this asymmetry decreases as the product is developed, deviations from the optimal timing of technology transfer will occur. We obtain a condition for the optimal timing to take place and show that the intensity of competition between potential buyers has countervailing effects on this condition. An empirical analysis of licensing contracts signed between biotechnology firms and large pharmaceutical firms confirms our theoretical predictions.

[1]  James Kalamas,et al.  The optimum time for drug licensing , 2003, Nature Reviews Drug Discovery.

[2]  Howard W. Smith,et al.  Department of Economics Discussion Paper Series Upstream Competition and Downstream Buyer Power Upstream Competition and Downstream Buyer Power , 2022 .

[3]  S. Vishwasrao,et al.  Royalties vs. fees: How do firms pay for foreign technology? , 2007 .

[4]  Massimo Motta,et al.  Competition Policy: Theory and Practice , 2004 .

[5]  Todd A. Surovell,et al.  The Tortoise and the Hare , 2000, Current Anthropology.

[6]  M. Shubik,et al.  Market structure and behavior , 1982 .

[7]  A. Rubinstein,et al.  The Nash bargaining solution in economic modelling , 1985 .

[8]  Ashish Arora,et al.  Does In-House R&D Increase Bargaining Power? Evidence from the Pharmaceutical Industry , 2004 .

[9]  A. Arora,et al.  Markets for Technology: The Economics of Innovation and Corporate Strategy , 2002 .

[10]  Gary P. Pisano,et al.  R&D Performance, Collaborative Arrangements and the Market for Know-How: A Test of the "Lemons" Hypothesis in Biotechnology , 1997 .

[11]  Josh Lerner,et al.  Contractibility and the Design of Research Agreements , 2004 .

[12]  Lars Stole,et al.  Intra-firm Bargaining under Non-binding Contracts , 1996 .

[13]  R. Merges,et al.  The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry , 2003 .

[14]  Graham Watt,et al.  The tortoise and the hare. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[15]  A. Raskovich,et al.  Ordered Bargaining , 2007 .

[16]  M. Drugov Information and Delay in an Agency Model , 2010 .

[17]  Matthew J. Higgins The Allocation of Control Rights in Pharmaceutical Alliances , 2006 .

[18]  Jay Pil Choi,et al.  Technology Transfer with Moral Hazard , 1996 .

[19]  Anna Levine,et al.  Licensing and Scale Economies in the Biotechnology Pharmaceutical Industry , 2009 .

[20]  S. Hart,et al.  HANDBOOK OF GAME THEORY , 2011 .

[21]  D. Fudenberg,et al.  Infinite-Horizon Models of Bargaining with One-Sided Incomplete Information , 1985 .

[22]  J. Gans,et al.  Vertical Integration in the Presence of Upstream Competition , 2004 .

[23]  Pedro Mendi,et al.  The Structure of Payments in Technology Transfer Contracts: Evidence from Spain , 2005 .

[24]  Lawrence M. Ausubel,et al.  Bargaining in Incomplete Information , 2002 .

[25]  Leslie M. Marx,et al.  Opportunism in Multilateral Vertical Contracting: Nondiscrimination, Exclusivity, and Uniformity: Comment , 2004 .

[26]  T. Cymet,et al.  The Truth about Drug Companies: How They Deceive Us and What to Do about It , 2006 .

[27]  Nicos Savva,et al.  The economics of licensing contracts. , 2008, Nature biotechnology.

[28]  Sean Nicholson,et al.  Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality , 2002 .

[29]  T. Khanna,et al.  The Structure of Licensing Contracts , 2003 .

[30]  Y. Tauman,et al.  Fees Versus Royalties and the Private Value of a Patent , 1986 .

[31]  A. Raskovich Competition or Collusion? Negotiating Discounts Off Posted Prices , 2013 .

[32]  James J. Anton,et al.  The Sale of Ideas: Strategic Disclosure, Property Rights, and Contracting , 2002 .

[33]  Randall Wright,et al.  Search and the market for ideas , 2010, J. Econ. Theory.

[34]  Leslie M. Marx,et al.  Opportunism in Multilateral Vertical Contracting : Nondiscrimination , Exclusivity , and Uniformity : Reply , 2004 .

[35]  A. Beggs The licensing of patents under asymmetric information , 1992 .